Skip Nav Destination
Issues
Pancreatic beta-cell glucokinase: closing the gap between theoretical concepts and experimental realities.
Diabetes March 1998, Vol.47, 307-315. doi:https://doi.org/10.2337/diabetes.47.3.307
Successful islet autotransplantation in humans: functional insulin secretory reserve as an estimate of surviving islet cell mass.
Diabetes March 1998, Vol.47, 324-330. doi:https://doi.org/10.2337/diabetes.47.3.324
Independent genetic regulation of T-cell and antigen-presenting cell participation in autoimmune islet inflammation.
Diabetes March 1998, Vol.47, 331-338. doi:https://doi.org/10.2337/diabetes.47.3.331
Alpha-ketoisocaproate is not a true substrate for ATP production by pancreatic beta-cell mitochondria.
Diabetes March 1998, Vol.47, 339-344. doi:https://doi.org/10.2337/diabetes.47.3.339
Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinct processes.
Diabetes March 1998, Vol.47, 345-351. doi:https://doi.org/10.2337/diabetes.47.3.345
Palmitate and myristate selectively mimic the effect of glucose in augmenting insulin release in the absence of extracellular Ca2+.
Diabetes March 1998, Vol.47, 352-357. doi:https://doi.org/10.2337/diabetes.47.3.352
Effects of depletion of mitochondrial DNA in metabolism secretion coupling in INS-1 cells.
Diabetes March 1998, Vol.47, 374-380. doi:https://doi.org/10.2337/diabetes.47.3.374
13C/31P NMR studies on the mechanism of insulin resistance in obesity.
Diabetes March 1998, Vol.47, 381-386. doi:https://doi.org/10.2337/diabetes.47.3.381
Insulin-induced hexokinase II expression is reduced in obesity and NIDDM.
M Pendergrass; J Koval; C Vogt; H Yki-Jarvinen; P Iozzo; R Pipek; H Ardehali; R Printz; D Granner; R A DeFronzo; L J Mandarino
Diabetes March 1998, Vol.47, 387-394. doi:https://doi.org/10.2337/diabetes.47.3.387
Troglitazone prevents hyperglycemia-induced but not glucosamine-induced insulin resistance.
Diabetes March 1998, Vol.47, 395-400. doi:https://doi.org/10.2337/diabetes.47.3.395
Stimulatory effect of glucose on macrophage lipoprotein lipase expression and production.
Diabetes March 1998, Vol.47, 431-438. doi:https://doi.org/10.2337/diabetes.47.3.431
Predisposition to essential hypertension and development of diabetic nephropathy in IDDM patients.
J A Fagerudd; L Tarnow; P Jacobsen; S Stenman; F S Nielsen; K J Pettersson-Fernholm; C Grönhagen-Riska; H H Parving; P H Groop
Diabetes March 1998, Vol.47, 439-444. doi:https://doi.org/10.2337/diabetes.47.3.439
Unselective inhibition of endothelin receptors reduces renal dysfunction in experimental diabetes.
Diabetes March 1998, Vol.47, 450-456. doi:https://doi.org/10.2337/diabetes.47.3.450
Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration.
A Veves; C M Akbari; J Primavera; V M Donaghue; D Zacharoulis; J S Chrzan; U DeGirolami; F W LoGerfo; R Freeman
Diabetes March 1998, Vol.47, 457-463. doi:https://doi.org/10.2337/diabetes.47.3.457
Abnormalities of retinal metabolism in diabetes or experimental galactosemia: V. Relationship between protein kinase C and ATPases.
Diabetes March 1998, Vol.47, 464-469. doi:https://doi.org/10.2337/diabetes.47.3.464
Identification and functional analysis of sulfonylurea receptor 1 variants in Japanese patients with NIDDM.
Y Ohta; Y Tanizawa; H Inoue; T Hosaka; K Ueda; A Matsutani; V P Repunte; M Yamada; Y Kurachi; J Bryan; L Aguilar-Bryan; M A Permutt; Y Oka
Diabetes March 1998, Vol.47, 476-481. doi:https://doi.org/10.2337/diabetes.47.3.476
Shortened telomere length in white blood cells of patients with IDDM.
Diabetes March 1998, Vol.47, 482-486. doi:https://doi.org/10.2337/diabetes.47.3.482
Human peroxisome proliferator-activated receptor-gamma2: genetic mapping, identification of a variant in the coding sequence, and exclusion as the gene responsible for lipoatrophic diabetes.
C Vigouroux; L Fajas; E Khallouf; M Meier; G Gyapay; O Lascols; J Auwerx; J Weissenbach; J Capeau; J Magré
Diabetes March 1998, Vol.47, 490-492. doi:https://doi.org/10.2337/diabetes.47.3.490
Transgenic mice deficient in the LAR protein-tyrosine phosphatase exhibit profound defects in glucose homeostasis.
Diabetes March 1998, Vol.47, 493-497. doi:https://doi.org/10.2337/diabetes.47.3.493
